Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis c
Symptom |infection
Sentences 498
PubMedID- 22894766 Chronic infection with hepatitis c virus (hcv) is the predominant aetiology for the development of hepatocellular carcinoma (hcc) worldwide .
PubMedID- 20516810 infection with hepatitis c virus (hcv) can be associated with demyelinating polyneuropathy that may be responsive to immunomodulatory therapy.
PubMedID- 22792259 Chronic infection with hepatitis c virus (hcv) is considered a major risk for chronic liver failure.
PubMedID- 21261982 Predisposing factors for the development of pct in hiv-1/aids patients are co-infection with hepatitis c, alcohol abuse and hepatotoxic drug consumption .
PubMedID- 23650587 Chronic infection with hepatitis c virus (hcv) is a global health problem affecting a significant proportion of world’s population.
PubMedID- 22829850 infection with hepatitis c virus (hcv) is affecting about 3% of the world's population, leading to liver damage, end-stage liver disease, and development of hepatocellular carcinoma, being thus the first indication for liver transplantation in the usa.
PubMedID- 24461160 Background: infection with the hepatitis c virus (hcv) has been considered a major cause of mortality, morbidity and resource utilisation in the us.
PubMedID- 20642483 Sex and age differences in lipid response to chronic infection with the hepatitis c virus in the united states national health and nutrition examination surveys.
PubMedID- 21886060 Background: hepatitis secondary to infection with the hepatitis c virus (hcv) is one of the most common causes of viral hepatitis worldwide.
PubMedID- 25691453 In japan, the infection rate of hepatitis c is high, with many cases of hepatocellular carcinoma (hcc) 1.
PubMedID- 22807544 Abnormal levels of liver enzymes are common in hiv-infected patients and may be caused by multiple factors, including co-infection with hepatitis c virus (hcv) or hepatitis b virus (hbv) infection and in the majority of cases by antiretroviral drug-related liver injury.
PubMedID- 20924215 Exclusion criteria included co-infection with hepatitis c, or the human immunodeficiency virus; evidence of cirrhosis or hepatocellular carcinoma; previous exposure to any nucleoside analog that is active against hbv; use of interferon alpha within 6 months before enrollment.
PubMedID- 25888935 Chronic infection with hepatitis c virus (hcv) affects approximately 170 million people worldwide, and it is associated with increased morbidity and mortality secondary to cirrhosis and hepatocarcinoma (hcc) 1.
PubMedID- 22593164 Expression of microrna mir-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis c virus.
PubMedID- 20950406 Chronic infection with the hepatitis c virus (hcv) is more prevalent than human immunodeficiency virus (hiv) infection, but more public health resources are allocated to hiv than to hcv.
PubMedID- 22826750 hepatitis a virus is a benign and asymptomatic disease, however when it happens in super infection with hepatitis c, it leads to more severe consequences such as liver diseases, acute liver failure and even fulminant hepatitis or death.
PubMedID- 23010773 Introduction: adverse effects appearing during combined peg-interferon and ribavirin antiviral treatment against chronic infection with the hepatitis c virus are a major cause for treatment failures and abrupt interruption.
PubMedID- 22914343 For infection with hepatitis c virus, when two studies were excluded in which diagnosis was based on questionnaires21,22 and a third in which it was based on analysis of oral fluid,56 estimates of prevalence ranged from 3·9% to 35·3% with substantial heterogeneity (χ2=257, p<0·0001; i2=95·3%, 95% ci 93·5–96·7).
PubMedID- 21407274 The prevalence of chronic infection with the hepatitis c virus (hcv) in patients with chronic kidney disease is higher than in the general population.
PubMedID- 21449783 Background: peginterferon-ribavirin therapy is the current standard of care for chronic infection with hepatitis c virus (hcv).
PubMedID- 21316532 Background: cirrhosis developing during chronic infection with the hepatitis c virus (hcv) poses a risk of anticipated liver-related death, therefore representing a dominant indication to anti-hcv therapy.
PubMedID- 26262613 Chronic infection with hepatitis c virus (hcv) can result in severe liver diseases, including cirrhosis and hepatocellular carcinoma 1.
PubMedID- 25837807 Initial infection with hepatitis c virus (hcv) is characterized by detection of virus in blood within 2–14 days of exposure, increases in hepatic transaminases, and appearance of detectable hcv-specific antibodies (anti-hcv) within 30–60 days of exposure .
PubMedID- 26519873 Background: recurrent infection with the hepatitis c virus (hcv) after liver transplantation is associated with decreased graft and patient survival.
PubMedID- 23300497 Occult hepatitis b virus infection in patients with chronic hepatitis c treated with antiviral therapy.
PubMedID- 23613990 Chronic infection with hepatitis c virus (hcv) leads to exhaustion and death of hcv-specific t-cells (reviewed in ) but may also cause defects in overall immune function.
PubMedID- 23304615 infection with hepatitis c virus (hcv) causes chronic liver disease in approximately 80% of cases, resulting in chronic inflammation and cirrhosis 1.
PubMedID- 22068808 Recent studies have shown however that cyclosporine suppresses viral replication and thus cannot exacerbate infection with hepatitis c when employed for treating patients with psoriasis.
PubMedID- 23575038 Chronic infection with hepatitis c virus (hcv) affects >170 million individuals, approximately 3% of the world population, and is responsible for approximately 350,000 deaths every year 1.
PubMedID- 25685452 These classes have been linked to respective clinical manifestations and depend on the stage of evolution of the host's immune response, extent of associated hepatic fibrosis and co-infection with salmonella or hepatitis c.
PubMedID- 22218720 Worldwide, infection with hepatitis c virus (hcv) is common among people who inject drugs (pwid).1 estimates suggest that >70% of new cases of hcv infection are associated with injecting drug use.2 3 epidemiological studies have identified independent risk factors for hcv infection, including sharing of contaminated needles and syringes4–7 and other injecting equipment,8 9 female gender,6 10 duration of injecting11 and intravenous cocaine use.12 13 although the risk factors for incident infection are well established, the literature suggests that a number of barriers may prevent pwid presenting for screening and many pwid face the possibility of hcv infection with a sense of inevitability, fostered by structural barriers to risk avoidance.14 pwid are a priority population in australia as hcv prevalence remains high in this group.
PubMedID- 22611419 Cytokines are intercellular mediators involved in viral control and liver damage being induced by infection with hepatitis c virus (hcv).
PubMedID- 21895746 Persistent infection with hepatitis c virus (hcv) is closely correlated with type 2 diabetes.
PubMedID- 25905096 Even if confounding factors, such as drug use and co-infection with hepatitis c virus (hcv) have been reported (18), more than 80% of pah cases in the hiv population are directly related to hiv and/or its treatment (19, 20).
PubMedID- 26034765 Overall, liver-related death, mainly due to chronic infection with hepatitis c virus (hcv) or hepatitis b virus, represents the most frequent cause of non-aids-related death 2.
PubMedID- 26288635 infection with hepatitis c virus (hcv) is a grave public health problem and medical issue in the world.
PubMedID- 20875187 Other independent risk factors were infection with hepatitis c (or 19.6, 95% ci 2.4, 164), age over 60 years (or 18.5, 95% ci 2.3, 151) and multi-drug-resistant tb (or 8.2, 95% ci 1.3, 53.6).
PubMedID- 21925048 Occult hepatitis b virus infection in patients with chronic hepatitis c: a hidden threat.
PubMedID- 25621684 Conversely to the trend with hbv infection, the median rate of hepatitis c virus (hcv) infection in asian patients was 16% (range, 1%–74%), significantly lower than the 25% (range, 4%–75%) in non-asian patients (p < 0.001).
PubMedID- 21175769 infection with hepatitis c virus (hcv) is a major risk factor for chronic hepatitis, cirrhosis and hepatocellular carcinoma.
PubMedID- 24296877 To investigate whether cygb can be utilized to distinguish hepatic stellate cells from myofibroblasts in normal and fibrotic human liver, human liver tissues damaged by infection with hepatitis c virus (hcv) and at different stages of fibrosis were obtained by liver biopsy.
PubMedID- 24693412 The inclusion criteria in this study were as follows: 1) lack of co-infection with hepatitis c virus or human immunodeficiency virus; 2) lack of other causes of liver disease, such as autoimmune hepatitis, and primary biliary cirrhosis; 3) no evidence of advanced liver diseases, such as decompensated cirrhosis, severe hepatitis, and hepatic carcinoma.
PubMedID- 21271404 In the multivariate analysis, low cd4 percentage, co-infection with hepatitis c or d viruses, hiv diagnosis before 1996 and hbeag positivity were independently associated with poor perceived overall health.
PubMedID- 25013557 Chronic infection with hepatitis c virus (hcv) continues to be the most common indication for orthotopic liver transplantation (olt) in the united states and western europe.
PubMedID- 22666173 Risk factors for infection with different hepatitis c virus genotypes in southern brazil.
PubMedID- 23735863 Our work represents the first case report of polycystic echinococcosis co-infection with hiv, hepatitis c virus (hcv), and hepatitis b virus (hbv).
PubMedID- 24040725 Results: a total of 1,583 hepatitis b cases, including 30 cases of co-infection with hepatitis c (hcv) was reported in 2011.
PubMedID- 26147631 Maternal hiv infection increased the risk of vertical transmission of hepatitis c.
PubMedID- 24713004 Chronic infection with hepatitis c virus (hcv) is a leading indicator for liver disease.
PubMedID- 21239793 Hepatocellular carcinoma and end-stage liver disease are increasing in the older hemophilia population due to infection with hepatitis c (hcv) and hcv/hiv coinfection.

Page: 1 2 3 4 5 6 7 8 9 10